Soligenix, Inc. earnings releases SNGX

Annual Quarterly

Soligenix, Inc. last reported quarterly results on Aug 12, 2016, for the quarter ended Jun 30, 2016. It usually reports 38–52 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38–52 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Aug 12, 2016 43 days after quarter end	— ended Jun 30, 2016	—	—	—
Aug 21, 2013 52 days after quarter end	— ended Jun 30, 2013	—	—	—
May 8, 2013 38 days after quarter end	— ended Mar 31, 2013	—	—	—
Aug 10, 2012 41 days after quarter end	— ended Jun 30, 2012	—	—	—
May 15, 2012 45 days after quarter end	— ended Mar 31, 2012	—	—	—
Aug 12, 2011 43 days after quarter end	— ended Jun 30, 2011	—	—	—
May 13, 2011 43 days after quarter end	— ended Mar 31, 2011	—	—	—
Nov 16, 2010 47 days after quarter end	— ended Sep 30, 2010	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: SNGX (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Princeton, NJ
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 812796
Former names: SOLIGENIX, INC. (until Nov 2, 2026); DOR BIOPHARMA INC (until Sep 29, 2009); ENDOREX CORP (until Oct 24, 2001); IMMUNOTHERAPEUTICS INC (until Apr 30, 1996)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.